IDH's strong FY25 hides a quieter story: Saudi breakeven slips out and a new regional risk lands
Integrated Diagnostics Holdings delivers 37% revenue growth and a 34.9% EBITDA margin, but pushes its flagship Saudi turnaround to 2028 while the Iran conflict becomes a live concern.
IDHC.L · Earnings Call · 2026-04-21
The headline: a 37% growth year, and a quiet slide in the flagship timeline
Integrated Diagnostics Holdings (IDH) closed 2025 with what management calls "another very strong year for the group": revenue up 37% year-on-year, adjusted net profit up 79%, and the EBITDA margin up over five points to 34.9%. Egypt remained the engine, contributing 84.6% of revenue, with test volumes up 11% and average revenue per test up 24% on a richer mix of radiology, radiotherapy and specialized diagnostics. “These trends also helped us further strengthen our average test per patient metric, which reached 4.6 tests per encounter” — Hend El Sherbini, Chief Executive Officer · 2026-04-21. The household service — still roughly a fifth of Egypt's revenue and a structural differentiator — and the CAIRO RAY radiology/radiotherapy push both contributed, even if radiology's share of revenue stayed flat at ~5%. But the more consequential development sits in the guidance and the regional outlook.The one real change: Saudi breakeven slides out two years
On the Q3 2025 call, management was unambiguous about the Kingdom: “For the EBITDA, we are expecting a breakeven by end of 2026” — Tarek Yehia, Head of Investor Relations · 2025-11-25. This quarter, asked the same question, the answer moved. “EBITDA is turning positive by 2028” — Tarek Yehia, Head of Investor Relations · 2026-04-21, said Tarek Yehia. That is a 12-to-24-month slip in the Saudi operation's payoff timeline — the market's principal anchor for the Saudi optionality story. The forward numbers are also softer than the narrative: a 2026 revenue target of SAR 18 million on a base that generated just SAR 5 million in 2025, still far short of the 7% of group revenue the five-year plan envisions. Branch cadence held (3 open, 6 more in 2026, 9 planned), but profitability moved out.A fresh regional risk and a thin buffer
The other genuinely new element is geopolitical. IDH imports essentially all its test kits — “We import all our kits. So nothing is produced in Egypt, almost nothing” — Hend El Sherbini, Chief Executive Officer · 2026-04-21 — and the CEO explicitly flagged the escalation of the U.S. conflict with Iran as a live threat to Jordan and Saudi. This is thematic confluence with the broader tape, where conflict in Iran has been among the highest-momentum global keywords through late 2025 and into 2026; other reporters this week (Genuine Parts, FSI) cite the same risk. For IDH the exposure is concrete: imported reagents on a dollar-linked cost base, plus regional demand sensitivity to any escalation.Management's 2026 guidance of 25% sales growth (10% price, 15% volume) at a stable 33–34% EBITDA margin — “For 2026, we are expecting an increase of 25% on sales, a 10% increase in prices and 15% from volume” — Tarek Yehia, Head of Investor Relations · 2026-04-21 — implies a notable deceleration from 2025, and the buffer is thin: inventory is secured only through August. If the pound weakens or freight rises, the margin band carries FX risk IDH can only partially hedge. Two prior-quarter threads were also quietly subdued this call. The ambition for household service to reach 40% of revenue — “I gave them actually a target of 40%” — Hend El Sherbini · 2025-09-15 on the earlier call — still sits at ~20%. And the dividend debate resurfaced: the board declared just USD 4.9 million, drawing a pointed analyst question about payout restraint against low Egypt capex. That contrast — a strong print with a slipping flagship timeline and a new regional overhang — is what makes this call more than another steady update.We remain mindful of evolving regional developments including the escalation of the U.S., Israel conflict with Iran in early 2026, which may introduce heightened uncertainty across the region, particularly in markets such as Jordan and Saudi Arabia.